Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mary Suits"'
Autor:
Robert T. Greenlee, Alan S. Go, Pamela N. Peterson, Andrea E. Cassidy‐Bushrow, Charles Gaber, Romel Garcia‐Montilla, Karen A. Glenn, Nigel Gupta, Jerry H. Gurwitz, Stephen C. Hammill, John J. Hayes, Alan Kadish, David J. Magid, David D. McManus, Deborah Multerer, J. David Powers, Liza M. Reifler, Kristi Reynolds, Claudio Schuger, Param P. Sharma, David H. Smith, Mary Suits, Sue Hee Sung, Paul D. Varosy, Humberto J. Vidaillet, Frederick A. Masoudi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 7 (2018)
BackgroundPrimary prevention implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected patients with left ventricular systolic dysfunction by delivering therapies (antitachycardia pacing or shocks) to terminate potentially lethal
Externí odkaz:
https://doaj.org/article/f2a62d6d0485472191f09795998620ca
Autor:
Alan H. Kadish, Stephen C. Hammill, Frederick A. Masoudi, Alan S. Go, Claudio Schuger, Romel Garcia-Montilla, David D. McManus, Liza M. Reifler, Deborah Multerer, Andrea E. Cassidy-Bushrow, Paul D. Varosy, Param P. Sharma, David J. Magid, Mary Suits, Karen A. Glenn, Robert T. Greenlee, Jerry H. Gurwitz, Sue Hee Sung, John J. Hayes, Charles Gaber, J. David Powers, Pamela N. Peterson, David H. Smith, Nigel Gupta, Kristi Reynolds, Humberto Vidaillet
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected patients with left ventricular systolic dysfunction by delivering therapies (antitachycardia pacing or shocks) to terminate potentially lethal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da444a30ac1eb5914023457e82867493
http://europepmc.org/articles/PMC5907599
http://europepmc.org/articles/PMC5907599
Autor:
Robert T Greenlee, Alan S Go, David J Magid, Pamela N Peterson, Andrea E Cassidy-Bushrow, Charles Gaber, Romel Garcia-Montilla, Karen A Glenn, Nigel Gupta, Jerry H Gurwitz, Stephen C Hammill, John J Hayes, Alan Kadish, David D McManus, Deborah Multerer, J. David Powers, Liza M Reifler, Kristi Reynolds, Claudio Schuger, Param P Sharma, David H Smith, Mary Suits, Sue Hee Sung, Paul D Varosy, Humberto J Vidaillet, Frederick A Masoudi
Publikováno v:
Circulation. 132
Introduction: Primary prevention implantable cardioverter defibrillators (ICDs) reduce mortality in select patients with left ventricular systolic dysfunction (LVSD). The occurrence of device therapies after ICD implantation in contemporary clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::549a7d95929b37296b4ce0119d2103a2
https://doi.org/10.1161/circ.132.suppl_3.16941
https://doi.org/10.1161/circ.132.suppl_3.16941
Autor:
Stephen C. Hammill, Frederick A. Masoudi, Frances Fiocchi, Liza M. Reifler, Alan S. Go, Humberto Vidaillet, Michael R. Lauer, Alan H. Kadish, Jonathan M. Doris, Deborah Multerer, Paul D. Varosy, Kristi Reynolds, Nigel Gupta, Param P. Sharma, Robert J. Goldberg, John J. Hayes, Pamela N. Peterson, Jane S. Saczynski, Jerry H. Gurwitz, Robert T. Greenlee, Karen A. Glenn, Claudio Schuger, David H. Smith, Aaron W. Miller, Nathaniel Jackson, Romel Garcia-Montilla, Andrea E. Cassidy-Bushrow, David J. Magid, Sue Hee Sung, Mary Suits
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 5(6)
Background— Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary prevention after randomized, controlled trials demonstrating that they reduce the risk of death in patients with left ventricular systolic dysfunction. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792c5874ec89de9deed18d9959e24e46
https://pubmed.ncbi.nlm.nih.gov/23170006
https://pubmed.ncbi.nlm.nih.gov/23170006